Finckenstein Friedrich Graf
Chief Medical Officer · IOVANCE BIOTHERAPEUTICS, INC.
Individual
- 2024
- Jun 9, 2026
- 9
Chief Medical Officer · IOVANCE BIOTHERAPEUTICS, INC.
Latest filing:
Finckenstein Friedrich Graf is Chief Medical Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). 9 SEC Form 4 filings on record going back to 2024, most recently on 9 June 2026.
The latest 18 SEC Form 4 transactions reported by Finckenstein Friedrich Graf.
InsiderAlpha's records for Finckenstein Friedrich Graf go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Insiders who have reported open-market trades at the same companies as Finckenstein Friedrich Graf. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Browse nearby insider profiles in alphabetical order.
Finckenstein Friedrich Graf is a corporate insider, tracked as Chief Medical Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 9 June 2026, one of 9 filings going back to 2024.
